“…With the steady development of GCE, first achieved in E. coli (Furter, 1998; L. Wang, Czaplinski, et al, 2001), its successful implementation has been realized in a number of cell types and organisms, including yeast (Hancock et al, 2010; Q. Wang & Wang, 2008), eukaryotic cell culture (Elsasser et al, 2016; Gautier et al, 2010; Hino et al, 2005; Mukai et al, 2008; Sakamoto et al, 2002; Xiao et al, 2013), C. elegans (Greiss & Chin, 2011; Parrish et al, 2012), Drosophila (Bianco et al, 2012; Elliott et al, 2014), zebrafish (Brown & Deiters, 2019; Chen et al, 2017; Liu et al, 2017), and mouse brain (Ernst et al, 2016; Kang et al, 2013; Maywood et al, 2018; Zheng et al, 2017). To implement GCE in these cells and organisms, the o‐tRNA was delivered in several different fashions including transient transfection (Hino et al, 2005; Sakamoto et al, 2002; Schmied et al, 2014; Xiao et al, 2013), viral transduction (Chatterjee et al, 2013; Shen et al, 2011; Zheng et al, 2017), genomic integration (Elsasser et al, 2016; Sakamoto et al, 2002), or injected as RNA (Infield et al, 2018; Noren et al, 1989; Saks et al, 1996). GCE methods have demonstrated that o‐tRNAs can be delivered with different methods as either DNA or RNA, and are stable, heritable, and tolerable in a variety of eukaryotic cells, zebrafish, and mice (Chen et al, 2017; Elsasser et al, 2016).…”